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Abstract—The aim of this work was to develop novel electrospun nanofiber meshes coated with a
biomimetic calcium phosphate (BCP) layer that mimics the extracellular microenvironment found
in the human bone structure. Poly(ε-caprolactone) (PCL) was selected because of its well-known
medical applications, its biodegradability, biocompatibility and its susceptibility to partial hydrolysis
by a straightforward alkaline treatment. The deposition of a calcium phosphate layer, similar to the
inorganic phase of bone, on PCL nanofiber meshes was achieved by means of a surface modification.
This initial surface modification was followed by treatment with solutions containing calcium and
phosphate ions. The process was finished by a posterior immersion in a simulated body fluid
(SBF) with nearly 1.5× the inorganic concentration of the human blood plasma ions. After some
optimization work, the best conditions were chosen to perform the biological assays. The influence
of the bone-like BCP layer on the viability and adhesion, as well as on the proliferation of human
osteoblast-like cells, was assessed. It was shown that PCL nanofiber meshes coated with a BCP layer
support and enhance the proliferation of osteoblasts for long culture periods. The attractive properties
of the coated structures produced in the present work demonstrated that those materials have potential
to be used for applications in bone tissue engineering. This is the first time that nanofiber meshes
could be coated with a biomimetic bone-like calcium phosphate layer produced in a way that the
original mesh architecture can be fully maintained.
Key words: Biomimetic calcium phosphate; polycaprolactone; electrospinning; nanofibers; osteoblast-
like cells; surface modification; biomimetic coating.
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INTRODUCTION
Poly(ε-caprolactone) (PCL) is a US Food and Drug Administration (FDA)-approved
polymer that is subjected to hydrolytic degradation due to the susceptibility of its
aliphatic ester linkage to hydrolysis [1, 2]. Due to the good mechanical properties
of this polymer and to its biocompatibility and biodegradability, scaffolds of PCL
have been used in different branches of tissue engineering, mainly in the applica-
tions where flexible materials are required, i.e., bone substitution and regeneration
[3, 4]. It is well known that, for bone-related applications, the ideal biodegradable
polymer scaffolds should have adequate osteointegration, as well as be character-
ized by osteoconduction and osteoinduction. These properties could facilitate the
integration with native bone and eventually promote new bone formation [5]. In
this sense, the hybridization of PCL with bioactive ceramics, such as hydroxyap-
atite (HA), to obtain scaffolds with the above-mentioned characteristics has been
shown to lead to very promising properties [2, 3]. Most of these hybrid scaffolds
are prepared by the dispersion of the mineral phase into the polymer matrix. How-
ever, those techniques are limited by the poor adhesion of the cells to the composite
surfaces. In this sense, the coating of polymers with a calcium phosphate layer
rendering the obtained structures with adequate bone-bonding or osteoconductive
properties has been evaluated [6–9]. Moreover, the presence of the calcium phos-
phates may tailor the degradation and resorption of the polymer matrix [2, 6, 10].
Additional benefits could involve the improvement in cell adhesion, proliferation
and eventually the osteogenic differentiation of progenitor cells [6, 8, 9, 11–14].
Among the techniques used to achieve this goal [15–18], biomimetic coatings are
very promising candidates. The coated polymers are characterized by a homoge-
nous distribution of a biomimetic calcium phosphate (BCP) phase at the polymer
surface. Based in this concept, Kokubo et al. [19] developed a methodology to
coat different inorganic and organic materials with bioactive layers. The main aim
of this biomimetic process is to mimic the biomineralization process at physiolog-
ical conditions, leading to the formation of a BCP layer on the surface of the sub-
strate. This approach has the advantage to coat porous three-dimensional structures
[15, 20]. The substrates coated with the calcium phosphate layer by the biomimetic
process have great potential for bone-repairing applications, since they can exhibit
high bioactivity and biocompatibility, as well as mechanical properties analogous
to the ones of natural cancelous bone [21, 22]. The original biomimetic method for
coating different substrates with BCP includes two steps. Initially, the substrates
are covered with a CaO–SiO2-based glass particles and immersed in a simulated
body fluid (SBF) [23], a solution with ion concentrations nearly equal to those of
human plasma, at 36.5◦C (first treatment designated as the nucleation period). Sub-
sequently, the substrates are immersed in another solution, e.g., 1.5× SBF, with ion
concentrations 1.5 times those of the SBF at 36.5◦C (second treatment designated
as the growth period). The thickness of the resulting BCP layer increases with the
immersion time in the second treatment. The rate of growth of the BCP layer in-
creases with the ion concentration of the second solution [21]. Such methodology,
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however, requires a long period to induce the nucleation of the calcium phosphate.
Furthermore, in biomedical applications it is required that the coatings have strong
adhesion of the inorganic layer to the substrate. In order to decrease the induction
period, as well as to increase the adhesion between the BCP layer and the polymer
surfaces, several chemical modifications can be achieved. Those modifications aim
at providing the polymer surfaces with chemical groups that can induce the calcium
phosphate nucleation by chemical interactions with the ions present in SBF. Differ-
ent functional groups, including –PO4H2, –COOH, Si–OH and Ti–OH, have been
shown to be effective for the calcium phosphate nucleation [24–29]. Therefore,
the period required for inducing the nucleation is a crucial factor in the calcium-
phosphate-forming ability of any material immersed in SBF. Parameters involved
in this type of modification include chemical nature [25], number [24] and arrange-
ment [27] of the functional groups at the surface. Oyane et al. [30] have shown that
BCP coating was formed at the surface of modified PCL membranes and porous
scaffolds in SBF. Those structures were previously treated with aqueous sodium
hydroxide (NaOH) solution and then dipped alternately in calcium and phosphate
ion solutions. Although this methodology has been proven efficient to coat materi-
als with 2D and 3D macrostructures, to our knowledge it is not the development of
studies concerning its application to structures with sub-micrometer characteristic
dimensions, such as meshes produced by electrospinning.
Electrospinning has been proposed extensively as an efficient technique for
the production of nanofibers of both synthetic and natural polymers [31–33].
Electrospun fibers present remarkable properties, namely an enhanced surface-area-
to-volume ratio due to the sub-micrometer range of the diameter of the fibers.
These structures have also high interconnectivity and porosity in the micrometer
range [34]. These properties and the fact that they can be easily manipulated
and shaped to fill anatomical defects, suggested its use in tissue/organ repair and
regeneration as biocompatible and biodegradable medical implant devices [35].
Another characteristic of electrospun nanofibers increasing its attractiveness for
those applications is their considerable similarity with the extracellular matrices
of tissues. It is believed that the meshes may consist in a more favorable
microenvironment for the cells to regenerate tissues [35–38]. Up to now, only few
studies have been undertaken to modify the electrospun polymer nanofibers in order
to induce the formation of BCP layers. A recent work describes the behavior in
SBF of electrospun nanofiber meshes of poly(L-lactic acid) (PLLA), another well-
known polyester, after surface modification using alkaline solutions [39]. Despite
the good results obtained, the surface-modified samples took a long period to
promote the nucleation of the calcium phosphate, at least 2 weeks. In the present
work, surface modification of electrospun PCL nanofiber meshes was achieved
using an aqueous NaOH solution. Afterwards, these surface-modified samples were
immersed alternately into solutions containing calcium ions and phosphate ions to
promote the precipitation of calcium-phosphate nuclei for the BCP to grow. In order
to induce the growth of the BCP layer, surface-modified specimens, as well as those
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subjected to the treatment with solutions containing calcium and phosphate ions,
were immersed in 1.5× SBF for several days. The conditions that produced BCP
coatings were chosen to perform the biological assays. It was evaluated the cell
attachment and proliferation of osteoblast-like cells seeded in the nanofiber meshes
coated with BCP layers.
MATERIALS AND METHODS
Preparation of electrospun nanofiber meshes
PCL (Mw = 80 × 103, Solvay Interox, UK) was dissolved in chloroform (Aldrich,
Germany)/dimethylformamide (DMF; Aldrich, Germany) (70:30) at a concentra-
tion of 17% (w/v). The obtained polymer solution was placed into a 5-ml syringe,
with a metallic needle having an internal diameter of 0.8 mm attached to it. The
syringe was connected to a syringe pump (KDS100, KD Scientific, USA) to control
the flow rate. A positive electrode was put in contact with the needle. Flat alu-
minum sheet covering the ground plate was used as the collector. A high voltage
power supply was employed to generate the electrostatic field (0–25 kV). The capil-
lary tip-to-collector distance and the flow rate were 15 cm and 1 ml/h, respectively.
The applied voltage was of 9 kV. From this procedure it was possible to obtain fibers
with diameters ranging from 250 nm to 2.5 µm. The conditions for the electrospin-
ning were optimized to obtain a continuous process and a reproducible morphology
of the meshes.
NaOH treatment
As-spun PCL nanofiber meshes were cut into a square shape (10 mm × 10 mm).
The specimens were immersed into a 0.5 M NaOH (Sigma, Germany) solution at
37◦C and stirred at 70 rpm for 12 h. After removal from the NaOH solution, the
specimens were washed five times with ultra-pure water and dried at 37◦C for at
least 5 h.
Calcium ion and phosphate ion treatments (CaP treatment)
The NaOH-treated specimens were dipped in 0.1 M CaCl2(Merck, Germany)
(10 samples for each 50 ml of the solution) at 37◦C with agitation at 70 rpm for
1 day. After removed from the calcium solution, the specimens were rapidly dipped
in 10 ml of ultra-pure water, immediately dipped in 10 ml of 0.1 M K2HPO4 · 3H2O
(Merck, Germany) for 15 min and immersed again in 10 ml of ultra-pure water for
a few seconds.
Immersion in simulated body fluid (SBF)
The NaOH-treated specimens and those subjected to the CaP treatment were dipped
in 10 ml of 1.5× SBF [23] for different time periods. The ion concentration
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(in mM: Na+ 243, K+ 7.5, Ca2+ 3.8, Mg2+ 2.6, Cl− 223, HCO−3 6.3, HPO2−4
1.5, SO2−4 0.8) of the 1.5× SBF solution was approx. 1.5-times higher than in
human blood plasma. 1.5× SBF was prepared by dissolving NaCl (Panreac,
Spain), NaHCO3 (Merck, Germany), KCl (Panreac, Spain), K2HPO4 · 3H2O
(Merck, Germany), MgCl2 · 6H2O (Aldrich, Germany), CaCl2 (Merck, Germany)
and Na2SO4 (Panreac, Spain) in ultra-pure water. The solution was buffered at
pH 7.4 with tris(hydroxymethyl)amino-methane (Aldrich, Germany) and 1 M HCl
(Panreac, Spain) at 37◦C.
Surface characterization
The morphology of the nanofiber meshes, cut into square shapes (10 mm×10 mm),
was characterized by Scanning Electron Microscopy (SEM) using a Leica Cam-
bridge S360 microscope equipped with an energy dispersive spectrometer (EDS;
link-eXL-II). Before SEM analysis, the specimens were sputter coated with gold
or with carbon (for EDS observations). Infrared spectra were obtained with a
Fourier transform infrared attenuated total reflection (FT-IR–ATR) spectrometer
(IRPrestige-21, Shimadzu, Japan). Static contact angles of the nanofiber meshes,
before and after NaOH treatment, were measured at room temperature with a
contact-angle measuring system (OCA 15plus, DataPhysics Instruments, Ger-
many). The used liquids (water, HPLC grade, 3 µl) were added by a motor driven
syringe in different regions of each sample. A X-ray photoelectron spectrometer
(XPS; VG Escalab 250 iXL ESCA), equipped with monochromatic Al-Kα radiation
(hν = 1486.92), was used to determine the surface composition of the specimens.
Thin-film X-ray diffraction (TF-XRD) patterns were recorded on a Philips X’Pert
MPD (Philips, The Netherlands) diffractometer using CuKα radiation.
Cells
Before being used in the biological studies, the samples were prepared as described
in the CaP-treatment, placed in 1.5× SBF for 4 days, washed with distilled water,
dried and sterilized with ethylene oxide, which were the best conditions to perform
the biological assays.
Direct cell contact experiments
Human primary osteogenic sarcoma cells (Saos-2; European Collection of Cell
Cultures, UK) were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM;
Sigma-Aldrich, Germany) supplemented with 10% heat-inactivated fetal bovine
serum (FBS; Biochrom, Germany) and 1% antibiotic–antimycotic solution (Gibco,
UK). The cells were maintained in a humidified atmosphere with 5% CO2 at 37◦C,
with medium changes every 2–3 days.
Direct contact assays were performed using both untreated PCL nanofiber meshes
and PCL nanofiber meshes coated with a BCP layer. Tissue-culture polystyrene
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(TCPS) surfaces were used as control. Saos-2 cells were seeded on the samples at
a density of 1 × 105 cells/cm2 (apparent surface area). The cells were cultured in
24-well cell-culture plates (Costar®; Corning, NY) for 1, 3, 7 and 14 days.
Morphological characterization of cultured cells
Adhesion, spreading and morphology of osteoblast-like cells seeded on coated PCL
nanofiber meshes and controls were assessed by SEM morphology analysis. At
the designated time points, the cells–nanofiber mesh constructs were first washed
with phosphate-buffered saline (PBS; Sigma, USA) and then fixed with 2.5%
glutaraldehyde (Sigma, USA) solution in PBS for 1 h at 4◦C. The samples were
further submitted to a dehydration process through a graded series of ethanol 25,
30, 50, 70, 80, 90 and 100% for 30 min each, and air-dried before mounting on
aluminum stumps.
Cell viability and proliferation assays
The CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega, USA)
is a colorimetric method for determining the number of viable cells in prolifera-
tion. This assay is based on the bioreduction of a tetrazolium compound, 3-(4,5-di-
methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfofenyl)-2H-tetrazolium
(MTS), by the cells into a brown formazan product that is soluble in tissue cul-
ture medium. This conversion is presumably accomplished by NADPH or NADH
produced by dehydrogenase enzymes in metabolically active cells. Briefly, cul-
ture medium was pipetted out from the 24-well tissue-culture plate and 500 µl of
fresh culture medium (without Phenol Red and FBS) was added to every well.
CellTiter 96® AQueous One Solution reagent (100 µl) was then added to every well.
After culturing for 3 h in the incubator, 100 µl/well of the colored culture medium
from each sample was transferred to a 96-well plate. The quantity of formazan
product, as measured by the amount of 490 nm absorbance in a microplate reader
(Synergie HT, Bio-Tek, USA), is directly proportional to the number of living cells
in culture.
Cell proliferation was quantified using the Quant-iT™ Picogreen® dsDNA Quan-
titation assay (Molecular Probes, Leiden, The Netherlands). According to the manu-
facturer, the Quant-iT™ PicoGreen® dsDNA reagent is an ultrasensitive fluorescent
nucleic acid stain for quantitating double-stranded DNA (dsDNA) in solution. The
fluorescence of the samples was measured using a fluorescence microplate reader
(Synergie HT, Bio-Tek, USA) at an excitation of 485 nm and emission of 528 nm.
A five-point standard curve ranging from 0 to 2 µg/ml was also created to allow the
determination of the DNA concentration of the samples. Appropriated blanks were
used to each group of samples (apatite-coated PCL nanofiber meshes, untreated
PCL nanofiber meshes and TCPS). Triplicates were made for each sample or stan-
dard used in the experiments. Statistically significant results from PCL nanofiber
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meshes coated with a BCP layer and untreated PCL nanofiber meshes were observed
in MTS and DNA quantification assays with the probability level set at P < 0.05.
RESULTS
Surface characterization of PCL nanofiber meshes
The contact-angle results with ultra-pure water at different periods of time for the
untreated and NaOH-treated PCL nanofiber meshes are shown in Fig. 1. There
was no significant variation observed in the contact angle for the untreated PCL
nanofiber meshes. However, for NaOH-treated specimens we observed a significant
reduction in the contact angle, which reached zero after only a few seconds. Those
results have shown how efficient the NaOH treatment is in promoting the decrease
in the interfacial tension between the liquid and the sample’s surface. This is an
important attribute to be considered during the CaP treatment, when electrostatic
interactions and ion-exchange reactions take place.
XPS analysis detected small amounts of sodium, probably present as sodium
carboxylate, on the NaOH-treated PCL nanofiber meshes (Fig. 2). The same
result was observed by Oyane et al. [30], where it was shown that the number of
carboxylate residues at the surface of the polymer increased with the concentrations
of the NaOH solutions.
The presence of calcium and phosphorus at the surface of the CaP-treated
specimens was also detected (Fig. 2). This result could be related to the early
formation of a calcium phosphate phase. Despite being identified by XPS, it was not
possible to detect calcium phosphate by infrared (Fig. 4) and TF-XRD analysis (data
not shown) immediately after CaP treatment. This could be due to the presence of
Figure 1. Contact-angle measurements of untreated and NaOH-treated PCL nanofiber meshes.
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Figure 2. XPS spectra of the surfaces of the untreated PCL nanofiber meshes (a) and those subjected
to NaOH treatment (b) and to CaP treatment (c).
the calcium phosphate as an amorphous phase not detectable by these techniques. In
fact, it has been reported that the infrared spectra of amorphous calcium phosphate
(ACP) do not show phosphate absorption bands, and, as it would be expected, it is
amorphous according to X-ray diffraction experiments [40]. Therefore, the absence
of calcium phosphate features in the TF-XRD and in the infrared spectra can also
be attributed to trace amounts of the calcium phosphate at the polymer surface [30].
After immersion in 1.5× SBF for 6 h, it was possible to detect the presence
of BCP on the CaP-treated specimens by TF-XRD analysis (Fig. 3). Although
the calcium phosphate layer formed in the first hours of immersion in 1.5× SBF
was predominantly amorphous, an increase in its crystallinity was observed as the
immersion time also increased.
The results of the FT-IR–ATR characterization (Fig. 4) show that the BCP-
containing PCL nanofiber meshes present the typical structural bands of PCL and
bands found in the mineral phase. The bands at 1727 and 1170 cm−1 can be
attributed to the C=O and C–O absorption bands of PCL, respectively [41, 42].
The contribution of the BCP is observed in the broad band at 1092–962 cm−1, the
absorption bands at 603 and 563 cm−1, corresponding to PO3−4 groups [43, 44],
and in the bands at 1415 and 875 cm−1, attributed to CO2−3 groups [39, 44]. The
presence of carbonate groups suggests the substitution of some phosphate groups,
which could be a result of the formation of a carbonated calcium phosphate similar
to the inorganic phase of bone, i.e., a bone-like apatite [45].
Figure 5 presents the morphological analysis by SEM of the samples immersed
in 1.5× SBF. It was possible to observe that a BCP layer was formed at the surface
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Figure 3. TF-XRD patterns of NaOH-treated (a) and CaP-treated PCL fiber meshes after immersion
in 1.5× SBF for 3 h (b), 6 h (c), 1 day (d), 4 days (e) and 7 days (f).
Figure 4. FT-IR–ATR spectra of PCL nanofiber meshes without treatment (a), NaOH-treated (b),
CaP-treated (c) and CaP-treated after immersion in 1.5× SBF for 2 days (d) and 4 days (e).
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Figure 5. SEM micrographs illustrating NaOH-treated (NT) and CaP-treated (CaPT) PCL nanofiber
meshes after immersion in 1.5× SBF for 3 h (CaPT-3h), 6 h (CaPT-6h), 2 days (NT-2d and CaPT-2d),
4 days (NT-4d and CaPT-4d) and 7 days (NT-7d and CaPT-7d).
of the CaP-treated specimens in the first hours of immersion. Furthermore, this
BCP layer was dense and deposited uniformly at the surface of the nanofibers,
keeping their morphology and, which is the most important, it did not promote
the obstruction of the pores. On the other hand, nanofiber meshes that were only
subjected to the NaOH treatement, were not able to induce the formation of a BCP
even after 7 days of immersion in 1.5× SBF.
Although the calcium phosphate phase on the CaP-treated specimens immersed
in 1.5× SBF could not be detected by TF-XRD before 6 h of incubation (Fig. 3),
the presence of calcium and phosphorus elements could be already detected by EDS
after 3 h of incubation (Fig. 6). EDS spectra also revealed the presence of carbon and
oxygen peaks. As the immersion time in 1.5× SBF increased, the intensity of the
peaks attributed to calcium and phosphorus elements was also increased, while the
relative intensity of the carbon and oxygen peaks decreased. Those results suggest
that the carbon and the oxygen detected belong mainly to the polymer phase, which
becomes less ‘detectable’ with increasing thickness of the BCP layer. In fact, in
Fig. 5 it can be seen that the thickness of the BCP layer increased with the time of
immersion in 1.5× SBF. Similar results were obtained in other works on biomimetic
calcium phosphate coatings of polymers [12, 46].
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Figure 6. EDS spectra of CaP-treated PCL nanofiber meshes after immersion in 1.5× SBF for 3 h (a),
6 h (b) and 1 day (c).
Osteoblast response to PCL nanofiber meshes coated with a biomimetic calcium
phosphate layer
Considering the morphological analysis, Saos-2 cells attached and proliferated
on all substrates tested after only 3 days in culture. However, some significant
differences in cell morphology were observed. A typical cube-shaped, epithelial-
like morphology of cells was observed on the untreated PCL nanofiber meshes
and TCPS materials (Fig. 7). Cells on these substrates had a round cellular body
and extended filipodia and microextensions, maintaining physical contact with
the substratum and the neighbor cells. In contrast, osteoblasts on PCL nanofiber
meshes coated with a BCP layer presented an elongated and flattened morphology.
Furthermore, the number of cells was kept at comparable levels between 7 and
14 days for osteoblast-like cells cultured on control materials. Conversely, on
coated samples, an increment of the cell number was observed, with almost all
the nanofiber mesh surface colonized. In both untreated and coated PCL nanofiber
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Figure 7. Morphology of Saos-2 cells cultured for 7 and 14 days on TCPS (A), untreated PCL
nanofiber meshes (B) and PCL nanofiber meshes coated with a biomimetic calcium phosphate
layer (C).
meshes it was possible to visualize more than one monolayer of cells, with
cytoplasms of different cells merging together.
The cell viability assay (MTS test) demonstrated that the cells remained viable
during the experiment, with consistently increase of the metabolic activity (Fig. 8).
The highest viability values were observed for longer (14 days) culture periods
on PCL nanofiber meshes coated with BCP. Earlier time points (1, 3 and 7 days)
evidenced that the osteoblast-like cells cultured on untreated PCL nanofiber meshes
present higher values of metabolic activities. Longer culture times tend to cause
cells to become fully confluent in a monolayer, resulting in a decrease of cell
viability.
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Figure 8. Cell viability of human osteoblast-like cells grown on PCL nanofiber meshes coated with
a biomimetic calcium phosphate layer (BCP PCL NFM) and untreated PCL nanofiber meshes (PCL
NFM). TCPS, tissue-culture polystyrene coverslips. *P = 5.76× 10−10, **P = 7.85× 10−8.
The DNA content of the osteoblast–nanofiber mesh constructs was measured to
quantify the osteoblast expansion and proliferation on the untreated and biomimeti-
cally calcium phosphate coated PCL nanofiber meshes. A remarkable increment of
DNA content was observed for coated PCL nanofiber meshes, reaching values simi-
lar to those observed for tissue culture polystyrene after 14 days (Fig. 9). The lowest
proliferation rate was observed in untreated PCL nanofiber meshes. The results of
morphological analysis were confirmed by the cell viability and proliferation.
DISCUSSION
Electrospinning has been proposed as a promising technique to produce scaffolds
consisting of non-woven fiber meshes with fiber diameters ranging from a few mi-
crometers down to the nanometer range. These structures have dimensions and
morphology resembling the extracellular matrix of human tissues. It is believed
that these structures provide the conditions necessary to support cell attachment,
proliferation and differentiation. It has been demonstrated that the highly intercon-
nected porous structure of the electrospun nanofibers together with a high surface
area allow an efficient transport of ions [39]. This is of extreme importance for
the good cell response to the structures supporting cell engraftment. Moreover, it
is relevant to produce coatings on polymer nanofibers without compromising their
original structure and morphology.
As was shown in Fig. 1, there was an accentuated decrease of the contact angle
values of samples subjected to the NaOH treatment. The increasing wettability of
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Figure 9. DNA content of human osteoblast-like cells grown on PCL nanofiber meshes coated with
a biomimetic calcium phosphate layer (BCP PCL NFM) and untreated PCL nanofiber meshes (PCL
NFM). TCPS, tissue-culture polystyrene coverslips. *P = 1.95× 10−10, **P = 4.04× 10−8.
Figure 10. Hydrolysis of PCL after NaOH treatment.
the PCL nanofiber meshes could be related to a partial hydrolysis of the polyester by
the strongly nucleophilic reagent, i.e., the hydroxide ion. This treatment may lead
to the cleavage of the ester linkages producing hydrophilic terminal groups, such as
carboxylate and hydroxyl groups [47], due to the formation of carboxylate salts and
alcohol as products. A probable scheme for this reaction is shown in Fig. 10.
The presence of carboxylate groups on PCL nanofiber meshes was not sufficient
to induce BCP coating after immersion in 1.5× SBF. On the other hand, samples
immersed in the calcium and phosphate solutions were shown to have the capacity
to induce the formation of a BCP layer after immersion in 1.5× SBF for several
time periods, as observed by SEM (Fig. 5). Moreover, the formation of the BCP
layer did not obstructed the pores of the nanofiber meshes. The BCP layer thickness
increased directly with the immersion time by consuming calcium and phosphate
ions from the solution. The thickness of the layer can be controlled by adjusting
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the time of immersion of the specimens in 1.5× SBF. The formation of the BCP
coating at the surface of the nanofiber meshes CaP-treated can be explained in
three steps: (i) when the NaOH-treated specimens are placed into the calcium
chloride solution, calcium ions can be attracted to the polymer surfaces by either
an electrostatic interaction and an ion-exchange between the sodium linked to the
carboxylate groups [30, 48]; (ii) after immersion in the phosphate solution, those
calcium ions will interact with the phosphate ions to promote the formation of
a calcium phosphate at the polymer surface, (iii) when immersed in 1.5× SBF, the
calcium phosphate formed on the polymer surface will act as a seed layer for the
BCP to grow by consuming the calcium and phosphate ions from the solution.
Since the carboxylate groups are believed to induce BCP nucleation when
immersed in SBF solution [25], it was expected that with only NaOH treatment
it would be possible to induce the formation of BCP. However, no BCP deposition
was observed even after 7 days of immersion in 1.5× SBF; this suggests that it is
necessary a period of incubation longer to induce the nucleation of the BCP. Chen
et al. [39] demonstrated that the incorporation of carboxylate groups in a PLLA
surface requires an immersion time in SBF longer than 2 weeks for the nucleation
of BCP.
As it was shown in Fig. 5, after immersion in 1.5× SBF for 7 days, the BCP layer
formed at the surface of CaP-treated PCL nanofiber meshes became more dense and
compact and started to obstruct the initial pores. Due to this, and in order to perform
the biological assays, it was chosen the samples that were immersed in 1.5× SBF
for 4 days, since they had a more uniform coating, preserving the initial aspect of
the pores and keeping their interconnectivity.
As stated in the results, human osteoblast-like cells were able to grow on both
biomimetically calcium-phosphate-coated and untreated PCL nanofibers. There-
fore, the cells tended to undergo cytoskeletal reorganization only when cultured in
the presence of the BCP. Shah et al. [49] hypothesized that when osteoblasts are
unable to adapt to a material surface they enhance many cell processes, in order
to produce sufficient anchorage proteins for attachment. In addition, they demon-
strated that cells with long cellular extensions also showed a larger cell size and
a lower attachment than cells with a compact cell shape. A similar behavior was
observed in this work (Fig. 7). The comparison of the morphological alterations
and cytoskeletal restructuring of osteoblast-like cells cultured on materials contain-
ing a BCP coating and on uncoated samples was also performed by other authors
[9, 14, 50, 51]. Furthermore, the crystallinity of the BCP may determine specific
cell response like the organization of cytoskeleton filaments and cell proliferation
mechanisms [52]. Reported results indicate that the proliferation of osteoblasts is
slower for more amorphous surfaces, mainly due to the development of less orga-
nized cytoskeleton. The BCP formed on CaP-treated specimens incubated in 1.5×
SBF for 7 days presented a superior crystallinity. However, as mentioned, the ac-
centuated variations of the morphology, when compared to the other CaP-treated
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samples incubated for shorter time periods, hindered their use in the biological as-
says.
The lower viability at short-cultured periods of the cells seeded on nanofiber
meshes coated with BCP, when compared to the cells seeded on untreated PCL
nanofibers, may be related to the calcium and phosphate ionic concentrations in
the cell microenvironment at early time points. The presence of these ions could
have a deleterious effect over cellular proliferation, as it was recently reported [53].
However, at longer culture periods (2 weeks), an enhanced osteoblast proliferation
was observed for the structures coated with the BCP, when compared to untreated
PCL nanofiber meshes. Similar results were also reported by Ciapetti et al. [3].
These authors reported the enhancement of the osteoblasts colonization on PCL
scaffolds reinforced with hydroxyapatite (HA) when compared to PCL scaffolds for
long-term culture periods. A large percentage of dead cells was also observed until
7 days of culture of preosteoblastic cells (MC3T3-E1 cell line) on precursor apatite
spheres, whereas after 14 days the remaining viable cells were able to proliferate
[54]. In the case of the coated nanofiber meshes, the increase in the cell proliferation
after two weeks of culture may be related to interactions of the BCP coating with
some substances present in the medium, leading to the formation of a more suitable
microenvironment for the cells. Indeed, it was reported previously that the calcium
phosphate layer can adsorb proteins from the culture medium that may enhance cell
proliferation and in general cell activity [55].
Previous studies [56, 57] had also evaluated the osteoblast attachment and
proliferation on composites of PCL nanofibers containing nanoparticles of calcium
carbonate (CaCO3) or HA. It was shown that the viability of the cells decreases as
the amount of CaCO3 in the composite increases [56]. In addition, cells seeded
on PCL/HA fibrous scaffolds presented higher viability than the cells seeded on
scaffolds containing PCL/CaCO3 or PCL alone [57]. That behavior was attributed
to the ability of HA to promote bone-cell activities.
The procedure used in this work has proven to be effective in coating electrospun
nanofiber meshes with BCP without compromising the initial morphology. This
procedure has several advantages when compared to other approaches, including the
fact that the coating process is compatible with physiological conditions. Moreover,
it promotes a homogeneous coating of the polymer surfaces with a mineral phase
with chemical composition similar to that found in bone. The positive aspects of the
coated structures were confirmed by the biological studies that showed increased
cell activities at longer time points when compared with untreated PCL samples.
CONCLUSIONS
The coating conditions were effective to induce the formation of a BCP layer
on PCL nanofiber meshes without damage their structures. The PCL nanofiber
meshes coated with BCP were more effective for supporting cell attachment and
proliferation when compared to untreated meshes for longer periods of time. The
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results point out that PCL nanofiber meshes coated with BCP can be considered for
bone-tissue engineering applications. This work is one of the first reports on the
coating of PCL nanofiber meshes with BCP layers.
Studies are already conducted to address the effect of the BCP formation at the
surface of PCL nanofiber meshes on osteogenic differentiation of human bone-
marrow-derived stromal cells (hBMSCs).
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